XML 66 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Segment information
 12 Months Ended
Dec. 28, 2024
Segment Reporting [Abstract]  
Segment information Segment information
The Company operates within targeted markets through three reportable segments for continuing operations: Fintech, Biotech, and Corporate and Other. Due the sale of Company’s Recycling segment during March 2023, it is being presented as discontinued operations for the years ended December 28, 2024 and December 30, 2023.
The following tables present our segment information (in $000’s):
For the Years Ended
December 28, 2024December 30, 2023
Revenue
Fintech$12,532 $— 
Biotech— — 
Corporate and other— — 
Discontinued operations— 3,795 
Total Revenues$12,532 $3,795 
Gross profit
Fintech$6,294 $— 
Biotech— — 
Corporate and other— — 
Discontinued operations— (197)
Total Gross profit$6,294 $(197)
Operating loss
Fintech$905 $— 
Biotech(2,148)(1,531)
Corporate and other(6,319)(18,315)
Discontinued operations— 10,438 
Total Operating loss$(7,562)$(7,562)$(9,408)
Depreciation and amortization
Fintech$1,316 $— 
Biotech2,086 1,452 
Corporate and other— — 
Discontinued operations— 96 
Total Depreciation and amortization$3,402 $1,548 
Interest (expense) income, net
Fintech$(499)$— 
Biotech— — 
Corporate and other(380)2,250 
Discontinued operations— (181)
Total Interest (expense) income, net$(879)$2,069 
Net loss after provision for income taxes
Fintech$469 $— 
Biotech(2,086)(1,532)
Corporate and other(4,628)(15,563)
Discontinued operations— 9,283 
Total net loss after provision for income taxes$(6,245)$(7,812)
As of
December 28, 2024		As of
December 30, 2023
Assets
Fintech$64,217 $— 
Biotech16,926 17,846 
Corporate and other1,293 641 
Discontinue operations— — 
Total Assets$82,436 $18,487 
Goodwill and other intangible Assets
Fintech$30,385 $— 
Biotech15,755 17,846 
Corporate and other4 — 
Discontinued operations— — 
Total goodwill and other intangible Assets$46,144 $17,846